Conference Coverage
Latest News
Study compares noninvasive treatments of cutaneous neurofibromas
The epidermis overlying cNF is normal, “so there is no reason to use nonselective or surgical methods and destroy a perfectly good epidermis when...
Conference Coverage
Answers sought for mental health challenges in pediatric rheumatology patients
One study found a tremendous increase in screening by automating the process while another found remote delivery of a 6-week cognitive-behavioral...
Conference Coverage
Parents of patients with rheumatic disease, MIS-C strongly hesitant of COVID vaccination
A single-center study and a survey of rheumatologists revealed similar levels of hesitancy among parents of both these populations.
Latest News
The earlier baricitinib for severe alopecia areata is started, the better
“If I can keep someone on 4 mg that’s great, but it looks like you can go to a lower dose and do a pretty good job,” Dr. Raj Chovatiya said.
Latest News
What are the clinical implications of recent skin dysbiosis discoveries?
Activities that can contribute to alterations in skin flora or skin dysbiosis include topical application of steroids, antibiotics, retinoids,...
Conference Coverage
Pretransfer visits with pediatric and adult rheumatologists smooth adolescent transition
The time from the last pediatric visit to the first adult visit was substantially shorter for patients who had a dual provider pretransfer visit...
Conference Coverage
Childhood lupus severity linked to social determinants of health
Social determinants of health were linked to lupus disease severity in children, but it will take more than awareness among doctors to address the...
Conference Coverage
Little change in rheumatology faculty coverage in pediatric residency programs in nearly 20 years
There has been little improvement in addressing the shortage of pediatric rheumatologists over the past 2 decades, boding poorly for future...
Conference Coverage
Impact of child abuse differs by gender
PARIS –
Latest News
JAK inhibitor ivarmacitinib shows efficacy for atopic dermatitis in a pivotal trial
The co-primary endpoints were change in IGA and EASI scores at 16 weeks, and both improved rapidly, showing statistical significance relative to...
Latest News
Topical delgocitinib shows promise for chronic hand eczema, pivotal trial shows
Delgocitinib is an investigational topical pan-JAK inhibitor that inhibits activation of the JAK-STAT pathway.